Interstrand Crosslink Resistance in Escherichia coli

Abstract:
8-methoxypsoralen is a photoac3vated DNA-intercala3ng agent, which a<er absorbing two high-energy UVA photons, covalently binds pyrimidine bases on both DNA strands, to form an interstrand crosslink (ICL). These lesions completely block replica3on and transcrip3on, and are widely used in chemotherapies; yet the mechanism by which they are processed remains poorly understood. In 1985, Ahmed and Holland reported an Escherichia coli mutant demonstra3ng hyper-resistance to ICL-inducing agents. The muta3on was mapped to 57.2 minutes on the chromosome, and poten3ally encoded a 55-kDa protein that was induced as part of the SOS response. Although these genes remain uniden3fied, hscA and hscB map to this loca3on, have a similar size, and are SOS-inducible. To determine if these genes or others might confer ICL resistance in E. coli, we characterized how cells survived PUVA treatment in the absence of HscAB, and when these gene products were overexpressed. In a second approach to screen for ICL resistance genes, we developed a selec3on system to isolate hyper-resistant strains through the sequen3al growth and exposure of wild-type cultures to PUVA. We found no effect on cell survival in the hscAB mutant compared to its wild-type parent, sugges3ng that HscAB may not be contribu3ng to ICL resistance as previously hypothesized. However, due to the significant cytotoxicity of plasmids containing hscAB, even in the absence of PUVA treatment, we were unable to determine whether over-expression of these gene products might provide a protec3ve effect to cells. Using itera3vely PUVA cells, we isolated strains that were >10 4 -fold more resistant to this ICL-inducing agent compared to the parent strain. This result suggests that E. coli possess mechanisms to repair or tolerate ICL's that contribute to resistance to these agents, similar to what is observed in human cancer cells.
Conclusion:
The absence of HscAB was found to have no measurable effect on cell survival following PUVA treatment.
Plasmids containing HscAB were toxic to cells even in the absence of PUVA treatment, such that overexpression of HscAB as a mechanism of ICL resistance could not be tested.
A popula3on of ICL hyper-resistant cells was isolated over successive genera3ons that had >10 4 magnitude of cell survival to PUVA treatment compared to its wild-type parent. Sequencing of this hyper-resistant strain will be performed to iden3fy genes contribu3ng to the altered phenotype. 
